Your browser doesn't support javascript.
loading
Association of antipsychotic use with raised eosinophil count.
Tsamakis, Konstantinos; Mueller, Christoph; Hortis, Ioannis; Kallergi, Maria; Tolos, Ioannis; Alevyzakis, Evangelos; Siafakas, Nikolaos; Ouranidis, Andreas; Tsiptsios, Dimitrios; Kympouropoulos, Stylianos; Spandidos, Demetrios A; Smyrnis, Nikolaos; Rizos, Emmanouil.
Afiliação
  • Tsamakis K; Second Department of Psychiatry, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens 12462, Greece.
  • Mueller C; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
  • Hortis I; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
  • Kallergi M; South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK.
  • Tolos I; Second Department of Psychiatry, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens 12462, Greece.
  • Alevyzakis E; Department of Biomedical Engineering, University of West Attica, Campus I, Athens 12243, Greece.
  • Siafakas N; Second Department of Psychiatry, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens 12462, Greece.
  • Ouranidis A; Second Department of Psychiatry, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens 12462, Greece.
  • Tsiptsios D; Second Laboratory of Microbiology, University General Hospital 'ATTIKON', National and Kapodistrian University of Athens, Medical School, Athens 12462, Greece.
  • Kympouropoulos S; Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54636, Greece.
  • Spandidos DA; Department of Neurophysiology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland SR47TP, UK.
  • Smyrnis N; Second Department of Psychiatry, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens 12462, Greece.
  • Rizos E; Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion 71003, Greece.
Exp Ther Med ; 21(5): 513, 2021 May.
Article em En | MEDLINE | ID: mdl-33791022
ABSTRACT
The current study aimed to assess the possibility of an association between first and second generation antipsychotic medication and raised eosinophil count. A total of 22 in-patients at the psychiatric unit of the University General Hospital 'Attikon', a tertiary hospital, were included in the present study. Patients had received antipsychotic monotherapy and did not have any co-morbidities or require additional treatments. Patients were monitored weekly and their eosinophil count was assessed. One-way ANOVA and summary measures analysis were applied to study the effect of time and medication type on the absolute eosinophil concentration (or relative percentage) for each patient. The differences in mean eosinophil concentrations or relative percentage by patient and time were also assessed. An increase in the absolute concentration and the relative percentage of eosinophils over time was observed in patients receiving Olanzapine, Haloperidol and Aripiprazole. However, there was no difference between individual medications. In conclusion, antipsychotics may be associated with increased eosinophil count over time; however, larger studies involving more patients and a longer follow-up are required to reach a definitive conclusion.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article